Gilead Sciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Gilead Sciences 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About GILD

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. 

CEO
Daniel P. O'Day
CEODaniel P. O'Day
Employees
17,000
Employees17,000
Headquarters
Foster City, California
HeadquartersFoster City, California
Founded
1987
Founded1987
Employees
17,000
Employees17,000

GILD Key Statistics

Market cap
184.80B
Market cap184.80B
Price-Earnings ratio
-56.11
Price-Earnings ratio-56.11
Dividend yield
2.13%
Dividend yield2.13%
Average volume
6.72M
Average volume6.72M
High today
$152.01
High today$152.01
Low today
$148.60
Low today$148.60
Open price
$151.34
Open price$151.34
Volume
5.24M
Volume5.24M
52 Week high
$157.29
52 Week high$157.29
52 Week low
$108.46
52 Week low$108.46

Stock Snapshot

The current Gilead Sciences(GILD) stock price is $148.99, with a market capitalization of 184.8B. The stock trades at a price-to-earnings (P/E) ratio of -56.11 and offers a dividend yield of 2.13%.

During the trading session on 2026-10-01, Gilead Sciences(GILD) shares reached a daily high of $152.01 and a low of $148.60. At a current price of $148.99, the stock is +0.3% higher than the low and still -2.0% under the high.

Trading activity shows a volume of 5.24M, compared to an average daily volume of 6.72M.

Over the past 52 weeks, Gilead Sciences(GILD) stock has traded between a high of $157.29 and a low of $108.46.

Over the past 52 weeks, Gilead Sciences(GILD) stock has traded between a high of $157.29 and a low of $108.46.

GILD News

Zacks 13h
Gilead Sciences Declines More Than Market: Some Information for Investors

Gilead Sciences (GILD Quick QuoteGILD - Free Report) ended the recent trading session at $149.45, demonstrating a -1.21% change from the preceding day's c...

Gilead Sciences Declines More Than Market: Some Information for Investors
Simply Wall St 1d
Gilead Sciences Tests Its Multi Platform Story On Questions Around Valuation

Gilead Sciences (GILD) is back in focus after securing a $2.5 million federal grant with research partners to pursue oral treatments for mosquito-borne flavivir...

Gilead Sciences Tests Its Multi Platform Story On Questions Around Valuation
Simply Wall St 7d
Does Expanded HIV Prevention Access Change The Bull Case For Gilead Stock?

Gilead Sciences expanded its royalty-free voluntary licensing agreements for lenacapavir to cover once-yearly HIV prevention in 120 mainly low and lower middle...

Does Expanded HIV Prevention Access Change The Bull Case For Gilead Stock?

Analyst ratings

77%

of 30 ratings
Buy
76.7%
Hold
20%
Sell
3.3%

People also own

Based on the portfolios of people who own GILD. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.